Correlation Between Oric Pharmaceuticals and CorMedix

Can any of the company-specific risk be diversified away by investing in both Oric Pharmaceuticals and CorMedix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oric Pharmaceuticals and CorMedix into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Oric Pharmaceuticals and CorMedix, you can compare the effects of market volatilities on Oric Pharmaceuticals and CorMedix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oric Pharmaceuticals with a short position of CorMedix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oric Pharmaceuticals and CorMedix.

Diversification Opportunities for Oric Pharmaceuticals and CorMedix

0.32

Correlation Coefficient

Oric Pharmaceuticals  CorMedix

Weak diversification

The 3 months correlation between Oric and CorMedix is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Oric Pharmaceuticals and CorMedix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CorMedix and Oric Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oric Pharmaceuticals are associated (or correlated) with CorMedix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CorMedix has no effect on the direction of Oric Pharmaceuticals i.e., Oric Pharmaceuticals and CorMedix go up and down completely randomly.

Pair Corralation between Oric Pharmaceuticals and CorMedix

Given the investment horizon of 90 days Oric Pharmaceuticals is expected to under-perform the CorMedix. But the stock apears to be less risky and, when comparing its historical volatility, Oric Pharmaceuticals is 1.89 times less risky than CorMedix. The stock trades about -0.02 of its potential returns per unit of risk. The CorMedix is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  935.00  in CorMedix on October 10, 2024 and sell it today you would earn a total of  95.00  from holding CorMedix or generate 10.16% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Oric Pharmaceuticals  vs.  CorMedix

Oric Pharmaceuticals

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Oric Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound forward indicators, Oric Pharmaceuticals is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

CorMedix

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in CorMedix are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain primary indicators, CorMedix exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Oric Pharmaceuticals and CorMedix

The main advantage of trading using opposite Oric Pharmaceuticals and CorMedix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oric Pharmaceuticals position performs unexpectedly, CorMedix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CorMedix will offset losses from the drop in CorMedix's long position.

The idea behind Oric Pharmaceuticals and CorMedix pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.